In summary, TRPM8 consistently exerts a negative impact on liver inflammation, tumors, fibrosis, and beyond, underscoring its potential as a viable target for the future development of TRPM8-targeted therapeutic interventions for liver diseases to mitigate adverse effects. This evidence concerns the gene TRPM8 and liver disorder.